I plan to cover the following two aspects in my presentation:
1. Anatomical and physiological factors affecting intranasal systemic and local drug delivery and implications on the design of the antigen delivery systems to be administered by nasal route. 2. Case-study: chitosan-based NPs for recombinant protein and DNA vaccines: the influence of the composition of the nanoparticles on the immune response generated
Upon completion, participants will be able to understand the requirements of an ideal nasal formulation.
Upon completion, participants will be able to know better the role of some excipients on nasal vaccine formulations.
Upon completion of the case study, participants will be able to know the characteristics of the chitosan nanoparticles and their potential as vaccine adjuvants.